JUN 13, 2019 9:57 PM PDT

Formation of Habitual Cannabis Use Drives Addiction

WRITTEN BY: C Reardon

According to a new study in Biological Psychiatry: Cognitive Neuroscience and Neuroimaging, published by Elsevier, shifting from brain systems controlling reward-driven use to habit-driven use is what differentiates between addicted heavy cannabis users and those who are not addicted, even if they are long-time users.

Through the use of brain imaging, this study monitored neural activity as cannabis users were shown images associated with their cannabis use. Researchers refer to this as drug cues. Based on their findings, it appears that although all users reported being heavy, long-term users, only some were truly dependent on the drug. 

It turned out that all users in the study had exaggerated responses in their ventral striatum, the region of the brain that recognizes and processes reward. With a strong connection to other emotion generators in the brain, this region is most active during the expectancy, and receipt of, monetary, social, and emotional rewards. 

However, those users that proved to be dependent on the drug had a noticeably larger response in the dorsal striatum as well. The dorsal striatum is the region of the brain where habits are formed. The dorsal striatum is heavily involved in the planning, execution, and automatization of our motor behavior.  

What this means is that heavy cannabis use is a result of changes in your brain's reward system, but this may not be an indicator of an addictive relationship with the drug. Addictive qualities are likely controlled by the brain system that promotes habit and habitual use. Those who were dependent on the drug saw changes in other regions of the brain as well.

With an increasing cannabis landscape, it is crucial to begin to understand what causes cannabis users to develop addictive qualities when it comes to this drug. In terms of treatment, these findings could be beneficial in assisting the many long-term, heavy users that are now addicted to this drug. 


 

About the Author
  • Chelsey is a content strategist and copywriter with a business degree. She has a background in public relations and marketing and enjoys writing about various topics, from health, to lifestyle, to women’s issues. Since 2016, she has written for a variety of online publications, earning well over 100,000 shares. She published her first book in 2019.
You May Also Like
MAR 19, 2020
Cardiology
MAR 19, 2020
Listening to Music Reduces Risk for Repeat Heart Attack
Around 700,000 people survive a heart attack in the US each year, with approximately 1 in 9 of these survivors experiencing subsequent episodes of chest pa...
MAR 20, 2020
Neuroscience
MAR 20, 2020
The Little Things Matter: The Mental Impact of Social Distancing
Image: Metropolitian State University of Denver The COVID-19 pandemic has caused social interactions, resources, and most aspects of daily life to halt ind...
MAR 22, 2020
Microbiology
MAR 22, 2020
Men Are More Susceptible to COVID-19 Than Women
More data is being gathered from an unfortunate and dramatic rise in the number of COVID-19 cases around the world....
MAR 24, 2020
Cannabis Sciences
MAR 24, 2020
Florida Won't Cap THC for Patients Under 21
Medical marijuana has been legal in Florida since 2016 when more than 70 percent of voters approved the related measure. In March 2020, Republican lawmaker...
MAR 24, 2020
Cell & Molecular Biology
MAR 24, 2020
Certain Drugs May Raise the Risk of a Severe COVID-19 Infection
ACEIs and ARBs may make coronavirus infections worse, which can help explain why older adults are faring so much worse....
MAR 30, 2020
Clinical & Molecular DX
MAR 30, 2020
Imaging Platform to Aid in Diagnosis of COVID-19
In the exponential growth of a rapidly spreading infectious disease, healthcare systems become overwhelmed, which can have a cascade of negative effects....
Loading Comments...